List view / Grid view
24 September 2014 | By Sigma-Aldrich
Merck KGaA , a leading company for innovative and top-quality high-tech products in the pharmaceutical, chemical and life science sectors, and Sigma-Aldrich announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion...
3 January 2013 | By EMD Serono; Pfizer Inc.
The majority of patients found Rebif Rebidose easy to use in a user trial...
1 August 2011 | By Merck KGaA
Merck Millipore has completed the acquisition of the microbiology business of Biotest AG...
25 January 2011 | By Novo Nordisk
EMD Millipore, announced an agreement with Novo Nordisk, to transfer the distribution of recombinant human insulin for cell culture media...
20 January 2011 | By Merck Serono
Merck Serono, announced today that Merck KGaA has signed a cooperation agreement with the Lead Discovery Center GmbH (LDC)...
19 January 2011 | By Merck KGaA
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUSa study...
17 January 2011 | By Andrew Lloyd & Associates
Agreement covers metabotropic glutamate receptor 4 (mGluR4) Positive Allosteric Modulator (PAM) drugs targeting Parkinson's disease...
20 July 2006 | By Dr Jan Hauss, Laboratory Manager, Merck KGaA
Today, electronic support for scientific research from the bench to the product is reality. For many years there has been an organic growth of different electronic systems in various areas of industry. The current challenge is to combine these electronic islands to form solid ground for integrated cost efficient systems.…
24 March 2006 | By Michaela Kroeger, Merck KGaA, Institute of Toxicology, Matthias Glückmann, Applied Biosystems, Mass Spectrometry and Proteomics
To date, hazard/risk assessment of new drugs and chemicals primarily relies on the investigation of toxicological endpoints from animal studies. In this field, the full range of genomics and proteomics technologies can be used in efforts to uncover the molecular mechanisms at work in response to xenobiotic exposure. These new…
